$2.46
-0.0195-0.79%
Last update: Nov 9, 7:15 PM
Biodexa Pharmaceuticals PLC
BDRXNASDAQ
The average analyst price target for Biodexa Pharmaceuticals is $80,000, 3225706.5% above the current price. The one analyst covering it rates it Buy. The latest change came on Feb 8, 2024, when Ladenburg Thalmann initiated coverage of Biodexa Pharmaceuticals with a Buy rating and a $80,000 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
